Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01217580

Pain Relief Study of Ultrasound Guided Transverse Abdominis Plane(TAP)Block

Analgesic Efficacy of Ultrasound Guided Transversus Abdominis Plane Block After Cesarean Delivery in Patients With a BMI > 30

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ochsner Health System · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if injecting a local anesthetic, or numbing medication, above each hip will decrease the amount of narcotic pain medicine that is typically required by a patient after a cesarean delivery. Ultrasound pictures will be used to guide placement of this injection. Either ropivicaine (a type of numbing medication called a local anesthetic) or a placebo (saline) will be injected. For 24 hours, you will be given a button to press when you have pain. When the button is pressed, you will be given a small amount of pain medication called hydromorphone through your IV. You will also be given a pain medication called ketorolac through your IV every 8 hours for 24 hours after surgery.

Conditions

Interventions

TypeNameDescription
DRUG0.5% ropivacaine20ml each side of the hip of 0.5% ropivacaine into the transverse abdominis plane after patient is brought to the recovery area after elective cesarean delivery
DRUG0.9% sodium chloride20ml each side of the hip of 0.9% sodium chloride into the transverse abdominis plane after patient is brought to the recovery area after elective cesarean delivery

Timeline

Start date
2010-10-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2010-10-08
Last updated
2023-04-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01217580. Inclusion in this directory is not an endorsement.